Article and Video CATEGORIES

Cancer Journey

Search By

SBRT for Oligometastatic Lung Cancer
Author
GRACE Videos and Articles
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend toward the use of stereotactic body radiation therapy to treat it.

 

Download Transcript

 

Transcript

First, let’s define the term “oligometastatic disease.” Oligometastatic disease typically means patients who have metastatic disease, but have a few metastases that, if they could be eradicated, their life could be prolonged. There are some good examples of the literature where patients have been resected, let’s say for metastatic colorectal cancer, or metastatic renal cancer, let’s say they had a brain metastasis that was resected and given curative therapy for their primary cancer, and there is about a 20-25% overall survival rate in that situation.

That, broadened out with the development of stereotactic body radiation therapy, has brought into play SBRT for patients with oligometastases for a variety of tumors. There is some recent literature in lung cancer, let’s say, that show that if you have patients with a few metastases that are receiving systemic therapy, that you can achieve median survivals approaching 20 months in metastatic lung cancer, and that’s previously unseen. That data was a trial from UT Southwestern and the University of Colorado groups, published this past year in the JCO — one of the most cited papers in the JCO this past year.

I think the oligometastatic patient population is a good patient population for focused radiation therapy. People ask, “what is oligometastasis?” It has classically been defined as patients with three or fewer metastases who have their remainder of the disease or the disease burden is under control with  systemic therapy; some have expanded that to five or six metastases. It typically doesn’t matter where they are. The classic example, of course, is a metastasis to the brain. We’ve applied this to patients in the lung, liver, spine, various places that are able to receive this focused radiation dose, and I think it’s a good tool, if chosen for the right patients, to extend their survival — perhaps we could even cure a few.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi Stan,

It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving.  I know it meant a...

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine that family and friends - our chosen family...

Recent Comments

JOIN THE CONVERSATION
Hey Bluebird,

I understand…
By JanineT GRACE … on
So good to hear from you Stan
By dbrock on
Hi Stan,

It's so good to…
By JanineT GRACE … on